Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Many treatments can help people with HIV live longer, more fulfilling lives. The main treatment for HIV is antiretroviral medication. Every year, researchers are investigating new therapies in the ...

What Are HIV/AIDS Medications? HIV medications can help lower your viral load, fight infections, and improve your quality of life. They can lower your chances of spreading HIV, but if you take ...

HIV doesn’t cause urinary symptoms on its own but may increase your risk of a health condition, such as a urinary tract infection or kidney damage, that can lead to symptoms. Living with HIV can ...

An HIV rash is a common symptom among people living with human immunodeficiency virus (HIV). In addition to a rash that appears as an early sign of HIV, you may be at risk for other types of rashes if ...

HIV-2 and HIV-1 are both types of human immunodeficiency virus (HIV). They are both transmitted the same way, but HIV-2 does not spread as easily and progresses to AIDS more slowly. Those with HIV-2 ...

New HIV cases in the U.S. have dropped by more than 75% compared with their peak in the mid-1980s, and the death rate has plummeted. We’ve also seen firsthand how much work is left to do.

AIDS (acquired immunodeficiency syndrome) is caused by the human immunodeficiency virus (HIV). This kills or impairs cells of the immune system and progressively destroys the body's ability to fight ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Updates from your News topics will appear in My News.

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

Current biomarkers of cognitive impairment in individuals with Alzheimer’s disease perform poorly. Now, a stronger predictor emerges.